Clinical Social Workers in Sparks, NV Accepting Medicare
48 Clinical Social Workers found. Showing 41 - 48
 Ms. Cheryl Marie Guerriero Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1321 N Mccarran Blvd Ste 104, Sparks, NV 89431 Phone: 530-494-9231 |
Ms. Debvorah Ramona Giorgi, LCSW, ACSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 390 Freeport Blvd Ste 3, Sparks, NV 89431 Phone: 775-501-5050 Fax: 775-501-5050 |
Cynthia Stephanie Nunez-gonzalez, LSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 438 Pyramid Way, Sparks, NV 89431 Phone: 775-378-2775 |
Amber Dawn Harrison, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1055 Roberta Ln Ste 103, Sparks, NV 89431 Phone: 775-356-0371 |
Angela Hiller, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 |
Mrs. Xochitl Lisa Salinas, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1083 Spoonbill Ct, Sparks, NV 89441 Phone: 530-310-5123 |
Vikki Erickson, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 480 Galletti Way, Sparks, NV 89431 Phone: 775-688-2001 Fax: 775-688-2192 |
Sharon M Willans, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2261 Pyramid Way Ste 5, Sparks, NV 89431 Phone: 775-322-4650 Fax: 775-322-3127 |
News Archive
RegeneRx's RGN-259 safe, well tolerated in patients with dry eye syndrome
RegeneRx Biopharmaceuticals, Inc. announced today that it has received the clinical study report for its recently completed Phase 2 clinical trial evaluating RGN-259 for the treatment of dry eye syndrome.
Prompt smoking cessation important for patients to receive CABG
Smoking cessation even a year prior to coronary artery bypass grafting (CABG) surgery does not fully normalize the changes smoking has made to the saphenous (leg) veins used for the surgery and may lead to later graft failure, according to a study published in the January 2013 issue of The Annals of Thoracic Surgery.
U.S. Army awards Oxygen Biotherapeutics two-year grant to study Oxycyte PFC emulsion against TBI
Oxygen Biotherapeutics, Inc. today announced it has received a $2.075 million, two-year grant from the U.S. Army to study the Company's proprietary Oxycyte PFC emulsion as a therapeutic intervention focused on reducing brain damage in victims of traumatic brain injury.
CBO: Republican 'fix' to health law would hurt coverage, cost $74 billion
The Congressional Budget Office report comes out as House Speaker John Boehner discusses whether there's a future for a GOP bill.
› Verified 6 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists